Schoumacher, C., Derangère, V., Dain, G. G., Huppe, T., Rageot, D., Ilie, A., . . . Ghiringhelli, F. CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSchoumacher, Coralie, et al. CD3-CD8 Immune Score Associated with a Clinical Score Stratifies PDAC Prognosis Regardless of Adjuvant or Neoadjuvant Chemotherapy. Taylor & Francis Group.
MLA (9th ed.) CitationSchoumacher, Coralie, et al. CD3-CD8 Immune Score Associated with a Clinical Score Stratifies PDAC Prognosis Regardless of Adjuvant or Neoadjuvant Chemotherapy. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.